Comparison between Atomoxetine and OROS Methylphenidate as an Adjunctive to SSRIs in Attention-deficit/Hyperactivity Disorder Adults with Comorbid Partially Responsive Major Depressive Disorder: A Head-to-head, 12-week, Randomized, Rater-blinded Clinical Trial

OBJECTIVE: This study aimed to compare the efficacy and safety of atomoxetine (ATX) and OROS methylphenidate (MPH) as adjunctive to selective serotonin reuptake inhibitors (SSRIs) in adults with attention-deficit hyperactivity disorder (ADHD) with comorbid partially responsive major depressive disor...

Descripción completa

Detalles Bibliográficos
Autores principales: Shim, Se-hoon, Woo, Young Sup, Kim, Ji Sun, Heo, In Soo, Yoon, Hee-jung, Sung, Hyung Mo, Lee, Jonghun, Bahk, Won-Myong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean College of Neuropsychopharmacology 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813317/
https://www.ncbi.nlm.nih.gov/pubmed/35078957
http://dx.doi.org/10.9758/cpn.2022.20.1.143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8813317/
https://www.ncbi.nlm.nih.gov/pubmed/35078957
http://dx.doi.org/10.9758/cpn.2022.20.1.143

Ejemplares similares